{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:39:00Z","timestamp":1793032740322,"version":"4.5.0"},"reference-count":272,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012493","name":"Jiangsu Province Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100596","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:40:15Z","timestamp":1782920415000},"page":"100596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liver fibrosis: Pathogenesis and innovative nanoparticle-based therapeutic strategies"],"prefix":"10.1016","volume":"12","author":[{"given":"Yibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100596_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: a recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0010","article-title":"Safety and efficacy of combined ezetimibe\/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease","volume":"15","author":"Abel","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijpx.2026.100596_bb0015","series-title":"Cellular Mechanisms of Liver Fibrosis","volume":"12","author":"Acharya","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100596_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/jtim-2017-0021","article-title":"Effect of pentoxifylline on histological activity and fibrosis of nonalcoholic steatohepatitis patients: a one year randomized control trial","volume":"5","author":"Alam","year":"2017","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91-92","author":"Alqudah","year":"2020","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpx.2026.100596_bb0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41577-026-01288-0","article-title":"Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers","volume":"26","author":"Araujo David","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.ijpx.2026.100596_bb0045","article-title":"Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy","volume":"17","author":"Armillotta","year":"2025"},{"key":"10.1016\/j.ijpx.2026.100596_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2026.100596_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis","volume":"44","author":"Arpino","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/ijms19051407","article-title":"From structure to phenotype: impact of collagen alterations on human health","volume":"19","author":"Arseni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0065","first-page":"L956","article-title":"\u03b2-Catenin signaling is required for TGF-\u03b21-induced extracellular matrix production by airway smooth muscle cells","volume":"301","author":"Baarsma","year":"2011","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.ijpx.2026.100596_bb0070","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2021.12.012","article-title":"Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis","volume":"27","author":"Baghaei","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpx.2026.100596_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151736","article-title":"Extracellular matrix molecular remodeling in human liver fibrosis evolution","volume":"11","author":"Baiocchini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpx.2026.100596_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2024.12.045","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"82","author":"Barb","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpx.2026.100596_bb0090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.kint.2016.05.026","article-title":"Hypoxia-inducible factor-1alpha promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3","volume":"90","author":"Baumann","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijpx.2026.100596_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0676.2001.210504.x","article-title":"Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA)","volume":"21","author":"Beljaars","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.ijpx.2026.100596_bb0100","article-title":"Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2","volume":"5","author":"Bell","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells7090137","article-title":"Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response","volume":"7","author":"Bobowski-Gerard","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100596_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"B\u00f6ttcher","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100596_bb0115","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.cgh.2024.12.039","article-title":"Biomarkers of histological response in Lanifibranor-treated patients with metabolic dysfunction-associated steatohepatitis","volume":"23","author":"Boursier","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0120","first-page":"NA57292","article-title":"Resmetirom, the first drug approved by the U.S. FDA for treating patients with nonalcoholic steatohepatitis","volume":"37","author":"Brett","year":"2024","journal-title":"NEJM J. Watch"},{"key":"10.1016\/j.ijpx.2026.100596_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-02854-x","article-title":"The roles and mechanisms of hypoxia in liver fibrosis","volume":"19","author":"Cai","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jpm16010001","article-title":"Targeted hepatic delivery of bioactive molecules via nanovesicles: recent developments and emerging directions","volume":"16","author":"Canestrale","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0135","series-title":"Targeted Hepatic delivery of Bioactive Molecules via Nanovesicles: Recent Developments and Emerging Directions","first-page":"16","author":"Canestrale","year":"2025"},{"key":"10.1016\/j.ijpx.2026.100596_bb0140","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v18.i31.4199","article-title":"Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells","volume":"18","author":"Chai","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0145","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.26790","article-title":"Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha\/C-X-C receptor type 4 axis and myeloid differentiation antigen\u2013positive myeloid cell infiltration in mice","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0150","doi-asserted-by":"crossref","first-page":"22613","DOI":"10.1002\/jcp.28827","article-title":"Dynamics of elastin in liver fibrosis: accumulates late during progression and degrades slowly in regression","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2023.05.002","article-title":"Delivery of hydroxycamptothecin via sonoporation: an effective therapy for liver fibrosis","volume":"358","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0160","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1039\/D3TB02790B","article-title":"Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents","volume":"12","author":"Chen","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijpx.2026.100596_bb0165","article-title":"Nanoparticle-based drug delivery systems: a promising approach for the treatment of liver fibrosis","volume":"10","author":"Chen","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ijpx.2026.100596_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41392-025-02532-0","article-title":"Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies","volume":"11","author":"Chen","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100596_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176552","article-title":"Loureirin B ameliorates cholestatic liver fibrosis via AKT\/mTOR\/ATG7-mediated autophagy of hepatic stellate cells","volume":"971","author":"Cheng","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/hep.31680","article-title":"Two faces of neutrophils in liver disease development and progression","volume":"74","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2015.10.007","article-title":"Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model","volume":"64","author":"Chung","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2015.10.007","article-title":"Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model","volume":"64","author":"Chung","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2024.06.028","article-title":"Fazirsiran for adults with Alpha-1 Antitrypsin Deficiency Liver Disease: a phase 2 placebo controlled trial (SEQUOIA)","volume":"167","author":"Clark","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of hepatic macrophages by therapeutic nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.120075","article-title":"CAT1 modulates hepatic fibrosis via IL-6-mediated inflammatory and fibrogenic pathways in hepatic stellate cells","volume":"1873","author":"Deng","year":"2026","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.ijpx.2026.100596_bb0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0215","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis\u2014updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100596_bb0220","first-page":"A18","article-title":"P17\u00a0Anticoagulation for liver fibrosis: a pilot study in hepatitis C infected patients","volume":"59","author":"Dhar","year":"2010"},{"key":"10.1016\/j.ijpx.2026.100596_bb0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2013.tb00510.x","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0230","series-title":"Interferon Regulatory Factors in Alcohol-Associated Liver Disease: Cell-Type Programs, Danger Signaling, and Therapeutic Opportunities","first-page":"92","volume":"48","author":"Dong","year":"2026"},{"key":"10.1016\/j.ijpx.2026.100596_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2017.01.025","article-title":"To heat or not to heat: challenges with clinical translation of thermosensitive liposomes","volume":"249","author":"Dou","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0240","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798873","article-title":"TCF\/LEF dependent and independent transcriptional regulation of Wnt\/\u03b2-catenin target genes","volume":"38","author":"Doumpas","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0245","article-title":"An autologous macrophage-based phenotypic transformation-collagen degradation system treating advanced liver fibrosis","volume":"11","author":"Duan","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ijpx.2026.100596_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","volume":"44","author":"Duarte","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15171\/mejdd.2018.103","article-title":"New concepts on reversibility and targeting of liver fibrosis; a review article","volume":"10","author":"Ebrahimi","year":"2018","journal-title":"Middle East J. Dig. Dis."},{"key":"10.1016\/j.ijpx.2026.100596_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.674786","article-title":"The potential application of magnetic nanoparticles for liver fibrosis theranostics","volume":"9","author":"Eftekhari","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijpx.2026.100596_bb0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"El Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100596_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.154020","article-title":"Preclinical liver toxicity models: advantages, limitations and recommendations","volume":"511","author":"Ezhilarasan","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0275","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0280","article-title":"Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy","volume":"230","author":"Fan","year":"2020","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0285","series-title":"Seminars in Cell & Developmental Biology","first-page":"115","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: Mechanisms and targets","author":"Finnson","year":"2020"},{"key":"10.1016\/j.ijpx.2026.100596_bb0290","first-page":"S1","article-title":"Nonalcoholic steatohepatitis\/metabolic dysfunction-associated steatohepatitis emerging market: preparing managed care for early intervention, equitable access, and integrating the patient perspective","volume":"30","author":"Flavin","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.ijpx.2026.100596_bb0295","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms20112700","article-title":"ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis","volume":"20","author":"Foglia","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0300","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2020.09.029","article-title":"Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis","volume":"74","author":"Frenette","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2026.100596_bb0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100596_bb0315","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0320","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.7150\/ijbs.28089","article-title":"Role of canonical Hedgehog signaling pathway in liver","volume":"14","author":"Gao","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110350","article-title":"\u0392-Catenin\/TCF4 inhibitors ICG-001 and LF3 alleviate BDL-induced liver fibrosis by suppressing LECT2 signaling","volume":"371","author":"Gao","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijpx.2026.100596_bb0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jconrel.2021.03.016","article-title":"Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis","volume":"332","author":"Geervliet","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0335","doi-asserted-by":"crossref","first-page":"38043","DOI":"10.1038\/s41598-025-21862-1","article-title":"Effect of nano-curcumin supplementation on liver fibrosis in patients with NAFLD-associated fibrosis: a double-blind randomized controlled trial","volume":"15","author":"Gerami","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100596_bb0340","article-title":"Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor","volume":"298","author":"Gu","year":"2023","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cytogfr.2025.08.002","article-title":"TLR-based therapeutic strategies for hepatocellular carcinoma","volume":"85","author":"Gupta","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijpx.2026.100596_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.09.004","article-title":"Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity","volume":"124","author":"Gupta","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.ijpx.2026.100596_bb0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","article-title":"Targeting TGF-\u03b2 signaling for the treatment of fibrosis","volume":"68","author":"Gy\u00f6rfi","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0360","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0365","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100596_bb0375","article-title":"Crosstalk network among multiple inflammatory mediators in liver fibrosis","volume":"25","author":"Han-Jing Zhangdi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0380","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb0385","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0395","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s11671-024-04118-1","article-title":"Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines","volume":"19","author":"Havelikar","year":"2024","journal-title":"Discover Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb0405","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/17425247.2024.2375400","article-title":"Understanding nanoparticle-liver interactions in nanomedicine","volume":"21","author":"He","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100596_bb0410","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/jgh.70037","article-title":"Unraveling liver cirrhosis: bridging pathophysiology to innovative therapeutics","volume":"40","author":"Hegazy Rabab","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2025.09.016","article-title":"Phase II INTEGRIS-PSC trial of bexotegrast, an \u03b1(v)\u03b2(6)\/\u03b1(v)\u03b2(1) integrin inhibitor, in primary sclerosing cholangitis","volume":"84","author":"Hirschfield","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0420","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/liv.15915","article-title":"Targeted inhibition of autophagy in hepatic stellate cells by hydroxychloroquine: an effective therapeutic approach for the treatment of liver fibrosis","volume":"44","author":"Hou","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.ijpx.2026.100596_bb0425","first-page":"406","article-title":"Engineered SPIONs functionalized with endothelin a receptor antagonist ameliorate liver fibrosis by inhibiting hepatic stellate cell activation","volume":"39","author":"Hove","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0430","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijpx.2026.100596_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114415","article-title":"A review of the effect of exosomes from different cells on liver fibrosis","volume":"161","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100596_bb0440","doi-asserted-by":"crossref","first-page":"19710","DOI":"10.1074\/jbc.RA118.004434","article-title":"Oligomerization of Frizzled and LRP5\/6 protein initiates intracellular signaling for the canonical WNT\/\u03b2-catenin pathway","volume":"293","author":"Hua","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100596_bb0445","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2018.11.008","article-title":"Activating Wnt\/\u03b2-catenin signaling pathway for disease therapy: challenges and opportunities","volume":"196","author":"Huang","year":"2019","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ijpx.2026.100596_bb0450","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0455","article-title":"Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation","volume":"299","author":"Huang","year":"2023","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111619","article-title":"m6A modified ATG9A is required in regulating autophagy to promote HSCs activation and liver fibrosis","volume":"127","author":"Huang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijpx.2026.100596_bb0465","article-title":"Late-breaking science abstracts and featured science abstracts from the American Heart Association\u2019s Scientific Sessions 2025 and late-breaking abstracts in resuscitation science from the Resuscitation Science Symposium 2025","volume":"152","author":"Ianping Li","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijpx.2026.100596_bb0470","series-title":"Evaluation of Folate-Functionalized Nanoparticle Drug Delivery Systems\u2014Effectiveness and Concerns","first-page":"2080","volume":"11","author":"Ibrahim","year":"2023"},{"key":"10.1016\/j.ijpx.2026.100596_bb0475","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","article-title":"Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Jara","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.069","article-title":"Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor","volume":"595","author":"Jiang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpx.2026.100596_bb0485","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40820-020-00550-x","article-title":"Applications of nanobiomaterials in the therapy and imaging of acute liver failure","volume":"13","author":"Jin","year":"2020","journal-title":"Nano Micro Lett."},{"key":"10.1016\/j.ijpx.2026.100596_bb0490","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0495","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0500","doi-asserted-by":"crossref","DOI":"10.4292\/wjgpt.v16.i3.110709","article-title":"Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: a systematic review","volume":"16","author":"Kamrul-Hasan","year":"2025","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.ijpx.2026.100596_bb0505","first-page":"1905","article-title":"In vivo siRNA delivery to immunosuppressive liver macrophages by \u03b1-mannosyl-functionalized cationic nanohydrogel particles","volume":"9","author":"Kaps","year":"2020"},{"key":"10.1016\/j.ijpx.2026.100596_bb0510","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122310119","article-title":"pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages","volume":"119","author":"Kaps","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100596_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411869","article-title":"Liver cell type-specific targeting by nanoformulations for therapeutic applications","volume":"24","author":"Kaps","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0520","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1258\/ebm.2010.009297","article-title":"Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model","volume":"235","author":"Kaushal","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ijpx.2026.100596_bb0525","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17425247.2017.1243527","article-title":"Strategies for improving drug delivery: nanocarriers and microenvironmental priming","volume":"14","author":"Khalid","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100596_bb0530","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cells8101249","article-title":"Mechanisms underlying hepatitis C virus-associated hepatic fibrosis","volume":"8","author":"Khatun","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100596_bb0535","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100596_bb0540","series-title":"The Liver: Biology and Pathobiology","first-page":"737","article-title":"Toll-like receptors in liver disease","author":"Kim","year":"2020"},{"key":"10.1016\/j.ijpx.2026.100596_bb0545","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/jcp.25572","article-title":"Wnt3A induces GSK-3\u03b2 phosphorylation and \u03b2-catenin accumulation through RhoA\/ROCK","volume":"232","author":"Kim","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.111044","article-title":"Hemistepsin a alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-\u03baB and Akt","volume":"135","author":"Kim","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0555","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.ymthe.2020.12.025","article-title":"sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p","volume":"29","author":"Kim","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100596_bb0560","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1021\/acsnano.1c08508","article-title":"Cholesterol-mediated seeding of protein corona on DNA nanostructures for targeted delivery of oligonucleotide therapeutics to treat liver fibrosis","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb0565","first-page":"2083","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014"},{"key":"10.1016\/j.ijpx.2026.100596_bb0570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0575","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0580","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2020.00480","article-title":"LOXL2 inhibition paves the way for macrophage-mediated collagen degradation in liver fibrosis","volume":"11","author":"Klepfish","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0585","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/j.gastro.2013.12.036","article-title":"Hepatic immune regulation and its involvement in viral hepatitis infection","volume":"146","author":"Knolle","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0590","first-page":"583","article-title":"High-throughput human microfluidic organoid-on-a-chip platform for modeling liver diseases and screening nanotherapeutics","volume":"24","author":"Kong","year":"2026","journal-title":"J"},{"key":"10.1016\/j.ijpx.2026.100596_bb0595","doi-asserted-by":"crossref","first-page":"G234","DOI":"10.1152\/ajpgi.00254.2021","article-title":"Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis","volume":"322","author":"Kostallari","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0600","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0605","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1007\/s00210-026-05179-y","article-title":"Dual ligand grafted liposomes for CD44 and CD206 targeted delivery of niclosamide against bisphenol A-induced hepatic fibrosis in albino Wistar rats: in vivo therapeutic efficacy and molecular pathway modulation","volume":"399","author":"Kumar","year":"2026","journal-title":"Naunyn Schmiedeberg\u2019s Arch"},{"key":"10.1016\/j.ijpx.2026.100596_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169387","article-title":"Chats and spats of autophagy and innate immune systems","volume":"437","author":"Kundu","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0615","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1038\/s41598-019-43759-6","article-title":"Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis","volume":"9","author":"Lachowski","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100596_bb0620","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2024.10.044","article-title":"Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles","volume":"376","author":"Lai","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0625","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0001036424.33995.a8","article-title":"S1764 Risk factors, clinical presentation and non-invasive liver fibrosis tests for advanced liver fibrosis in biopsy diagnosed metabolic dysfunction-associated steatotic liver disease or steatohepatitis","volume":"119","author":"Lau","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0630","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jgh.15726","article-title":"Effects of autophagy inhibition by chloroquine on hepatic stellate cell activation in CCl4-induced acute liver injury mouse model","volume":"37","author":"Le","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0635","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3350\/cmh.2023.0485","article-title":"Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Le","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0640","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-022-29186-8","article-title":"Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100596_bb0645","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/cells8101279","article-title":"Magnetic-assisted treatment of liver fibrosis","volume":"8","author":"Levada","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100596_bb0650","article-title":"Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0655","article-title":"Transforming growth factor \u03b2 latency: a mechanism of cytokine storage and signalling regulation in liver homeostasis and disease","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0660","article-title":"Supramolecular nanoarchitectonics based on antagonist peptide self-assembly for treatment of liver fibrosis","volume":"19","author":"Li","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100596_bb0665","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1021\/acs.nanolett.2c04726","article-title":"The combination of sinusoidal perfusion enhancement and apoptosis inhibition by Riociguat plus a galactose-PEGylated bilirubin multiplexing nanomedicine ameliorates liver fibrosis progression","volume":"23","author":"Li","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpx.2026.100596_bb0670","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.gendis.2022.08.013","article-title":"Interplays of liver fibrosis-associated microRNAs: molecular mechanisms and implications in diagnosis and therapy","volume":"10","author":"Li","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.ijpx.2026.100596_bb0675","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.actbio.2023.06.032","article-title":"CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis","volume":"168","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0680","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500101","article-title":"Tissue-microenvironment-responsive self-assembling peptide nanoshells boost pirfenidone efficacy in the treatment of liver fibrosis","volume":"14","author":"Li","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2026.103283","article-title":"Bioactive lipid nanoparticles as active rehabilitative regulators for fibrotic microenvironment remodeling","volume":"95","author":"Li","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.ijpx.2026.100596_bb0690","article-title":"Remodeling collagen microenvironment in liver using a biomimetic nano-regulator for reversal of liver fibrosis","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ijpx.2026.100596_bb0695","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122531119","article-title":"A two-component protein condensate of the EGFR cytoplasmic tail and Grb2 regulates Ras activation by SOS at the membrane","volume":"119","author":"Lin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100596_bb0700","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.32299","article-title":"A strategy of vascular-targeted therapy for liver fibrosis","volume":"76","author":"Lin","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0705","article-title":"Ponatinib alleviates non-alcoholic steatohepatitis through TFEB-mediated autophagy","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0710","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.30616","article-title":"Spermidine confers liver protection by enhancing NRF2 signaling through a MAP1S-mediated noncanonical mechanism","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0715","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","article-title":"Neutrophils in liver diseases: pathogenesis and therapeutic targets","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0720","article-title":"Carbon nitride-based siRNA vectors with self-produced O2 effects for targeting combination therapy of liver fibrosis via HIF-1\u03b1-mediated TGF-\u03b21\/Smad pathway","volume":"12","author":"Liu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0725","doi-asserted-by":"crossref","first-page":"1133297","DOI":"10.3389\/fimmu.2023.1133297","article-title":"Exosomes in liver fibrosis: the role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0730","series-title":"Exosomes in Liver Fibrosis: The Role of Modulating Hepatic Stellate Cells and Immune Cells, and Prospects for Clinical Applications","author":"Liu","year":"2023"},{"key":"10.1016\/j.ijpx.2026.100596_bb0735","doi-asserted-by":"crossref","first-page":"20861","DOI":"10.1021\/acsnano.4c02380","article-title":"Delivery strategy to enhance the therapeutic efficacy of liver fibrosis via nanoparticle drug delivery systems","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb0740","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2601425","article-title":"Cell-specific roles of autophagy in liver fibrosis: implications for targeted pharmacotherapy","volume":"57","author":"Liu","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113997","article-title":"Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis","volume":"385","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0750","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1039\/D4NR04469J","article-title":"Leveraging the dual role of ROS in liver diseases with nanomaterials: clearing and amplifying for therapy","volume":"17","author":"Liu","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpx.2026.100596_bb0755","article-title":"Macrophage membrane-coated NIR light-photodegradable carbon nitride-based gene vectors for gas-gene therapy of liver fibrosis","volume":"324","author":"Liu","year":"2026","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb0760","first-page":"378","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008"},{"key":"10.1016\/j.ijpx.2026.100596_bb0765","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40005-024-00699-2","article-title":"Extracellular vesicles as drug delivery systems in therapeutics: current strategies and future challenges","volume":"54","author":"Lu","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijpx.2026.100596_bb0770","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2016.01.010","article-title":"Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers","volume":"64","author":"Lua","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115740","article-title":"Targeting collagen homeostasis for the treatment of liver fibrosis: opportunities and challenges","volume":"215","author":"Luangmonkong","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0780","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/db25-778-P","article-title":"778-P: Pemvidutide, a balanced GLP-1\/glucagon dual receptor agonist, enhances reverse cholesterol transport in a Golden Syrian hamster model","volume":"74","author":"Lucca Andrade","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.ijpx.2026.100596_bb0785","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0790","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1021\/acsami.2c19269","article-title":"Albumin-based silibinin nanocrystals targeting activated hepatic stellate cells for liver fibrosis therapy","volume":"15","author":"Luo","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100596_bb0795","article-title":"Destruction complex dynamics: Wnt\/\u03b2-catenin signaling alters Axin-GSK3\u03b2 interactions in vivo","volume":"146","author":"Lybrand","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.ijpx.2026.100596_bb0800","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007880","article-title":"Frizzled and LRP5\/6 receptors for Wnt\/\u03b2-catenin signaling","volume":"4","author":"Macdonald","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0805","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2017.10.017","article-title":"Hedgehog signalling in liver pathophysiology","volume":"68","author":"Machado","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0810","series-title":"The Extracellular Matrix: Methods and Protocols","first-page":"1","article-title":"The complex interplay between extracellular matrix and cells in tissues","author":"Manou","year":"2019"},{"key":"10.1016\/j.ijpx.2026.100596_bb0815","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","article-title":"CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis","volume":"159","author":"Mejias","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0820","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/hep.28988","article-title":"Hepatostat: liver regeneration and normal liver tissue maintenance","volume":"65","author":"Michalopoulos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0825","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1021\/acsnano.5b03569","article-title":"Accelerating the translation of nanomaterials in biomedicine","volume":"9","author":"Mitragotri","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb0830","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/j.2040-4603.2022.tb00210.x","article-title":"Oxidative stress and redox signaling in the pathophysiology of liver diseases","volume":"12","author":"Mooli","year":"2022","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0835","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/his.13665","article-title":"Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease","volume":"73","author":"Munsterman","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0840","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0b013e32834c37ee","article-title":"Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update","volume":"22","author":"Musso","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0845","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.livres.2018.03.003","article-title":"Cytokines and fatty liver diseases","volume":"2","author":"Niederreiter","year":"2018","journal-title":"Liver Res."},{"key":"10.1016\/j.ijpx.2026.100596_bb0850","series-title":"Collagen","first-page":"1","article-title":"Molecular structure and functions of collagen","author":"Nimni","year":"2018"},{"key":"10.1016\/j.ijpx.2026.100596_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123723","article-title":"Comprehensive study of the murine MASH models\u2019 applicability by comparing human liver transcriptomes","volume":"376","author":"Ning","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0860","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/S0140-6736(25)02114-2","article-title":"Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study","volume":"406","author":"Noureddin","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpx.2026.100596_bb0865","series-title":"Seminars in Cancer Biology","first-page":"134","article-title":"Extracellular matrix proteins in metastases to the liver\u2013composition, function and potential applications","author":"Nystr\u00f6m","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100596_bb0870","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","article-title":"Extracellular matrix remodeling in chronic liver disease","volume":"2","author":"Ortiz","year":"2021","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.ijpx.2026.100596_bb0875","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100596_bb0880","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.27649","article-title":"Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1","volume":"61","author":"Pan","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb0885","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb0890","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/joa.12760","article-title":"Quantitative analysis of hepatic macro- and microvascular alterations during cirrhogenesis in the rat","volume":"232","author":"Peeters","year":"2018","journal-title":"J. Anat."},{"key":"10.1016\/j.ijpx.2026.100596_bb0895","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100596_bb0900","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt\u2013\u03b2-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0905","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14209","article-title":"CONTROL: a randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients","volume":"39","author":"Pockros","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.ijpx.2026.100596_bb0910","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100596_bb0915","doi-asserted-by":"crossref","DOI":"10.5662\/wjm.v14.i2.91319","article-title":"Non-alcoholic fatty liver disease in type 2 diabetes: emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies","volume":"14","author":"Pramanik","year":"2024","journal-title":"World J. Methodol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0920","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jconrel.2020.02.049","article-title":"Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis","volume":"321","author":"Qiao","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0925","doi-asserted-by":"crossref","first-page":"2309690","DOI":"10.1002\/adfm.202309690","article-title":"Kupffer cell teleportation\u201d strategy for liver fibrosis alleviation based on hybrid polymer- bimetallic sequential delivery system","volume":"34","author":"Qiu","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb0930","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/cts.13581","article-title":"Pharmacokinetics, safety, and tolerability of BMS-986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment","volume":"16","author":"Qosa","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb0935","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100596_bb0940","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/antiox9121279","article-title":"Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver","volume":"9","author":"Ramos-Tovar","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijpx.2026.100596_bb0945","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s44324-025-00083-0","article-title":"Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies","volume":"3","author":"Raza","year":"2025","journal-title":"NPJ Metab. Health Dis."},{"key":"10.1016\/j.ijpx.2026.100596_bb0950","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jconrel.2022.06.031","article-title":"Prebiotic-like cyclodextrin assisted silybin on NAFLD through restoring liver and gut homeostasis","volume":"348","author":"Ren","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb0955","series-title":"Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis","first-page":"2071","volume":"370","author":"Richeldi","year":"2014"},{"key":"10.1016\/j.ijpx.2026.100596_bb0960","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021907","article-title":"Regulation of the bioavailability of TGF-\u03b2 and TGF-\u03b2-related proteins","volume":"8","author":"Robertson","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0965","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","article-title":"Latent TGF-\u03b2-binding proteins","volume":"47","author":"Robertson","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0970","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68","author":"Roderfeld","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0975","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis (translational aspects)","volume":"68","author":"Roeb","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107935","article-title":"Liver targeted nanomedicine for treatment of fibrosis and hepatocellular carcinoma: emerging strategies in ligand-guided, stimuli-responsive and gene-based delivery","volume":"116","author":"Sahu","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2022.100127","article-title":"Fibrosis resolution in the mouse liver: role of Mmp12 and potential role of calpain 1\/2","volume":"17","author":"Sato","year":"2023","journal-title":"Matrix Biol. Plus"},{"key":"10.1016\/j.ijpx.2026.100596_bb0990","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1572-0241.2007.01759.x","article-title":"Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study","volume":"103","author":"Schepke","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb0995","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1000","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41575-025-01068-6","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpx.2026.100596_bb1010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114472","article-title":"Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis","volume":"161","author":"Shan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100596_bb1020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","article-title":"Human hepatic stellate cell isolation and characterization","volume":"53","author":"Shang","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jgh.16203","article-title":"Recent advances in the role of exosomes in liver fibrosis","volume":"38","author":"Shen","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1030","series-title":"Impaired TIM4-mediated Efferocytosis by Liver Macrophages Contributes to Fibrosis in Metabolic Dysfunction\u2013associated Steatohepatitis","volume":"17","author":"Shi","year":"2025"},{"key":"10.1016\/j.ijpx.2026.100596_bb1035","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid\u2013bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb1040","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/ijms24021506","article-title":"The importance of the immune system and molecular cell signaling pathways in the pathogenesis and progression of lung cancer","author":"Smok-Kalwat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb1045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpx.2026.100596_bb1050","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","article-title":"Reversibility of liver fibrosis","volume":"39","author":"Sun","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12951-021-00843-2","article-title":"Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors","volume":"19","author":"Sun","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108803","article-title":"Natural polysaccharide-based smart CXCR4-targeted nano-system for magnified liver fibrosis therapy","volume":"35","author":"Sun","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ijpx.2026.100596_bb1065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.actbio.2020.09.014","article-title":"A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy","volume":"116","author":"Surendran","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100596_bb1070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/cmi.2016.63","article-title":"Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells","volume":"15","author":"Tan","year":"2018","journal-title":"Cell. Molec. Immunol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2026.100596_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125906","article-title":"Mesoporous polydopamine based biominetic nanodrug ameliorates liver fibrosis via antioxidation and TGF-\u03b2\/SMADS pathway","volume":"248","author":"Tang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100596_bb1090","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1021\/acsami.2c22579","article-title":"Liver-targeted delivery of small interfering RNA of C\u2013C chemokine receptor 2 with tetrahedral framework nucleic acid attenuates liver cirrhosis","volume":"15","author":"Tian","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100596_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103819","article-title":"Pirfenidone encapsulated in succinylated gelatin-coated liposomes exhibits sustained antifibrotic effects in vitro models of renal, pulmonary, and hepatic fibrosis","volume":"114","author":"Togami","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and challenges in the translation of cancer nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083481","article-title":"Therapy of experimental NASH and fibrosis with galectin inhibitors","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpx.2026.100596_bb1110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2468-1253(25)00208-0","article-title":"Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial","volume":"11","author":"Trauner","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity\u2014metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijpx.2026.100596_bb1120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1130","article-title":"Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose","volume":"16","author":"Tung","year":"2024"},{"key":"10.1016\/j.ijpx.2026.100596_bb1135","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ijpx.2026.100596_bb1140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.15773","article-title":"The signalling and functional role of the extracellular matrix in the development of liver fibrosis","volume":"52","author":"Villesen","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijpx.2026.100596_bb1145","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/febs.17305","article-title":"Macrophages and autophagy: partners in crime","volume":"292","author":"Vitaliti","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpx.2026.100596_bb1150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2016.03.042","article-title":"Targeting the PDGF-B\/PDGFR-\u03b2 interface with destruxin A5 to selectively block PDGF-BB\/PDGFR-\u03b2\u03b2 signaling and attenuate liver fibrosis","volume":"7","author":"Wang","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijpx.2026.100596_bb1155","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.7150\/jca.15786","article-title":"Hedgehog signaling non-canonical activated by pro-inflammatory cytokines in pancreatic ductal adenocarcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijpx.2026.100596_bb1160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijpx.2026.100596_bb1165","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbadis.2013.02.007","article-title":"Tissue mechanics and fibrosis","volume":"1832","author":"Wells","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpx.2026.100596_bb1170","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/gutjnl-2014-308325","article-title":"CD248\/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism","volume":"65","author":"Wilhelm","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ijpx.2026.100596_bb1175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s40495-018-0147-0","article-title":"Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity","volume":"4","author":"Woolbright","year":"2018","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.ijpx.2026.100596_bb1180","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/polym12091903","article-title":"The effect of matrix stiffness on human hepatocyte migration and function\u2014an in vitro research","volume":"12","author":"Xia","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.ijpx.2026.100596_bb1185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.actbio.2023.07.035","article-title":"Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles","volume":"168","author":"Xiang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100596_bb1190","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/hep.26511","article-title":"Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice","volume":"58","author":"Xie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpx.2026.100596_bb1195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41580-019-0172-9","article-title":"Mechanisms of 3D cell migration","volume":"20","author":"Yamada","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2019.11.017","article-title":"Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells","volume":"320","author":"Yan","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijpx.2026.100596_bb1205","article-title":"Extra- and intra-cellular mechanisms of hepatic stellate cell activation","volume":"9","author":"Yan","year":"2021","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb1210","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2026.100596_bb1215","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpx.2026.100596_bb1220","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41467-019-09046-8","article-title":"Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100596_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148277","article-title":"Nanoparticle-mediated liver targeted delivery of IFN-\u03b3 confers enhanced anti-fibrotic efficacy with reduced systemic toxicity","volume":"330","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1240","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/acsmaterialslett.2c00839","article-title":"Antifibrotic and antioxidant effects of a tetrahedral framework nucleic acid-based chlorogenic acid delivery system","volume":"5","author":"Yao","year":"2023","journal-title":"ACS Mater. Lett."},{"key":"10.1016\/j.ijpx.2026.100596_bb1245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157322","article-title":"A comprehensive review of smart thermosensitive nanocarriers for precision cancer therapy","volume":"26","author":"Yaramiri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100596_bb1250","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1021\/bc060006z","article-title":"Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats","volume":"17","author":"Ye","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpx.2026.100596_bb1255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/cancers10060183","article-title":"Clinico-pathological importance of TGF-\u03b2\/phospho-smad signaling during human hepatic fibrocarcinogenesis","volume":"10","author":"Yoshida","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ijpx.2026.100596_bb1260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2021.06.031","article-title":"Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo","volume":"336","author":"You","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb1265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jconrel.2023.08.021","article-title":"Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice","volume":"361","author":"Younis","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb1270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2024.10.012","article-title":"Nano-encapsulation of drugs to target hepatic stellate cells: toward precision treatments of liver fibrosis","volume":"376","author":"Yuan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb1275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-Smad signaling pathways of the TGF-\u03b2 family","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1280","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.redox.2016.12.021","article-title":"Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell","volume":"11","author":"Zhang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.intimp.2019.05.055","article-title":"Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2\/Bax and PI3K\/AKT signaling pathways","volume":"73","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1290","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100596_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111572","article-title":"Hepatic stellate cell senescence in liver fibrosis: characteristics, mechanisms and perspectives","volume":"199","author":"Zhang","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ijpx.2026.100596_bb1300","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/biof.1764","article-title":"Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells","volume":"47","author":"Zhang","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.ijpx.2026.100596_bb1305","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.3748\/wjg.v30.i40.4393","article-title":"Elafibranor: a promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease","volume":"30","author":"Zhang","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1310","article-title":"The dual-target nanoparticles with ROS sensitivity inhibit the hedgehog signaling pathway and decrease oxidative stress in activated hepatic stellate cells to alleviate liver fibrosis","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpx.2026.100596_bb1315","article-title":"Signaling pathways that activate hepatic stellate cells during liver fibrosis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.ijpx.2026.100596_bb1320","doi-asserted-by":"crossref","first-page":"889","DOI":"10.5009\/gnl250008","article-title":"Serial liver stiffness measurement and serum biomarkers are not strong predictors of the regression of fibrosis among chronic hepatitis B patients receiving antiviral therapy based on triple liver biopsies","volume":"19","author":"Zhang","year":"2025","journal-title":"Gut Liver"},{"key":"10.1016\/j.ijpx.2026.100596_bb1325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114864","article-title":"New insights into therapeutic strategies for targeting hepatic macrophages to alleviate liver fibrosis","volume":"158","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1330","article-title":"Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis","volume":"324","author":"Zhang","year":"2026","journal-title":"Biom. J."},{"key":"10.1016\/j.ijpx.2026.100596_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126437","article-title":"Advanced strategies based on nanomedicine for liver fibrosis treatment","volume":"688","author":"Zhang","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100596_bb1340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12951-023-01876-5","article-title":"Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100596_bb1345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13619-025-00224-2","article-title":"Autophagy in adult stem cell homeostasis, aging, and disease therapy","volume":"14","author":"Zhao","year":"2025","journal-title":"Cell Regener."},{"key":"10.1016\/j.ijpx.2026.100596_bb1350","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41401-024-01333-5","article-title":"Rab11b promotes M1-like macrophage polarization by restraining autophagic degradation of NLRP3 in alcohol-associated liver disease","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpx.2026.100596_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102889","article-title":"Nanotechnology for diagnosis and therapy of idiopathic pulmonary fibrosis: recent advances and future perspectives","volume":"66","author":"Zhao","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100596_bb1360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","article-title":"Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis","volume":"343","author":"Zhou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100596_bb1365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2022.08.065","article-title":"Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy","volume":"152","author":"Zhou","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100596_bb1370","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2023.05.039","article-title":"Macrophage-derived cathepsin S remodels the extracellular matrix to promote liver fibrogenesis","volume":"165","author":"Zuo","year":"2023","journal-title":"Gastroenterology"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:04:20Z","timestamp":1793030660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":272,"alternative-id":["S2590156726001167"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100596","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis: Pathogenesis and innovative nanoparticle-based therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100596"}}